Iron oxide |
Quantum dot |
Cervical cancer |
[77] |
Iron oxide |
Quantum dot |
Cervical cancer and neural cells |
[75] |
Iron oxide |
Carbon dots |
Cervical cancer |
[76] |
Silica with iron oxide nanoparticles |
Rhodamine dye |
Neuroblastoma |
[78] |
Encapsulation
|
Nanoparticles
|
Optical Agent
|
Application
|
Reference
|
Silica with iron oxide nanoparticles |
Rhodamine dye |
Neuroblastoma |
[78] |
Mesoporous silica nanoparticles (MSNs) with Gd-DTPA |
Heptamethine dye (IR-808) |
Glioblastoma |
[79] |
Silica with iron oxide nanoparticles |
Quantum dots |
Mammary carcinoma |
[80] |
Dispersion
|
Nanoparticles
|
Optical Agent
|
Application
|
Reference
|
Copolyarylene ether nitriles with iron oxide nanoparticles |
Quantum dots |
Mammary carcinoma |
[81] |
Ethylene oxide polymer vesicles and iron oxide nanoparticles |
(7-Diethylamino coumarin)-3-carboxyic acid (DEAC-CA) |
Cervical cancer |
[82] |
Polymeric micelles and MnFe2O4 magnetic nanoparticles |
Quantum dots |
Glioblastoma |
[83] |
Polymeric matrix with iron oxide nanoparticles |
Chlorin e6 dye (Ce6) |
Colon cancer |
[84] |
Liposome with iron oxide nanoparticles |
Texas Red dye |
Ovarian cancer |
[85] |